Unlocking the Challenges of Uncontrolled Hypertension
Published: 28 June 2024
-
Views:
7591
-
Likes:
7
-
Views:
7591
-
Likes:
7
-
Up Next -
8m 18sPart 1 | Session 2 Panel Discussion
-
2m 21sPart 2 | Session 1 Case Presentation Continued
-
5m 37sPart 2 | Session 2 Audience Polls & Panel Discussion
-
11m 36s
-
22m 27sPart 4 Audience Q&A
Overview
The long term clinical implications of uncontrolled hypertension are well documented, but almost half of those with hypertension remain inadequately treated. In this symposium, our panel of three leading hypertension experts, Prof Thomas Weber (Klinikum Wels-Grieskirchen, Wels, AT), Prof Bryan Williams (University College London, London, UK) and Prof Erika Jones (University of Cape Town, Cape Town, SA), examine the current state of medical therapy, the barriers to optimal treatment and the underlying mechanisms driving uncontrolled hypertension, including the pivotal role played by aldosterone.
Presented, and recorded, at ESH 2024, in Berlin, DE. ay also be interested in: Cracking the Code of Uncontrolled Hypertension – S
Learning Objectives
- Describe the long-term clinical impact of uncontrolled hypertension
- Apply guideline-directed management to a patient case study
- Evaluate the challenges and limitations of current management options for uncontrolled hypertension
- Describe the role of aldosterone in uncontrolled hypertension
Target Audience
- Hypertension (Htn) Specialists
- Cardiologists / Internists
- Nephrologists
- GPs with an Interest in Htn
More from this programme
Part 1
Clinical Impact of Uncontrolled Htn and Case Presentation
In this first part, Prof Williams presents a patient case of a 56 year old male with a 20+ year history of hypertension. He presents the primary investigations and following this the panel discuss what is driving the uncontrolled hypertension, the clinical risk and current guideline-directed options.
| 2 sessions | |
| Case Presentation | Watch now |
| Panel Discussion | Watch now |
Part 2
Current Treatment Barriers and Limitations
Following presentation of the secondary investigations, the panel further discuss the underlying cause. Prof Weber then runs two audience polls to understand the significant cause of uncontrolled hypertension and barriers for currently available drugs to treat uncontrolled hypertension in your clinical practice. Following this, the panel discuss issues with the current Htn standard of care.
Part 3
What Drives Uncontrolled Hypertension?
Prof Jones presents on other contributing factors for uncontrolled hypertension. She discusses adherence, the pathophysiology of hypertension, second line therapy and pheontyping patients.
Part 4
Audience Q&A
The session closes with an engaging audience Q&A.
| 1 session | |
| Audience Q&A | Watch now |
Faculty Biographies
Thomas Weber
Associate Professor
Dr Thomas Weber is an Austrian cardiologist. He is Deputy Director of the Cardiology Department at the Klinikum Wels-Grieskirchen, in Wels, Austria.
His clinical interests cover interventional cardiology, heart failure and hypertension while his scientific interests are pulsatile hemodynamics, arterial stiffness, vascular aging, 24-hour hemodynamics, heart failure, coronary artery disease, hypertension, aortic disease and renal denervation.
During his scientific career, he has authored 80 original articles, 61 review articles, 15 editorials, 14 international and national guidelines and consensus papers and 10 book chapters.
Bryan Williams
Chair of Medicine
Bryan Williams is Chair of Medicine at UCL and Chief Scientific and Medical Officer at the British Heart Foundation. He is also a Consultant Physician at University College London Hospitals (UCLH) where he was previously Director of the NIHR UCLH/UCL Biomedical Research Centre and Director of Research for UCLH (2014-2023).
Prof Williams research and specialist clinical practice is in the field of hypertension in which he is recognised as one of the world's leading authorities and is credited with driving changes in clinical practice globally. He has been a NHS Consultant Physician in front line care for 40 years. He has received numerous national and international awards and was the recipient of the Times Higher Education University award, for “Outstanding Innovation and Technology” 2011 and the Sleight Award (2014) by the European Society of Hypertension for his "outstanding contribution to research, education and clinical practice in the field of…
Erika SW Jones
Nephrology and Hypertension Specialist
Erika Jones is Associate Professor in the Division of Nephrology and Hypertension at the University of Cape Town and Groote Schuur Hospital in Cape Town, SA.
Dr Jones interests are particularly in hypertension, having done her PhD in this area. One of the aspects of hypertension that she is studying currently and which is of major concern to nephrologists in Cape Town, is the rising incidence of young hypertensives with end stage renal disease in relation to methamphetamine usage.